Effects of Isotretinoin on the Growth Rate and Thickness of the Nail Plate
NCT ID: NCT04660916
Last Updated: 2020-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
70 participants
OBSERVATIONAL
2019-10-22
2020-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
isotretinoin
The patients aged 18-45 that were planned to begin treatment with isotretinoin for acne
Isotretinoin
The effects of isotretinoin on morphology, growth rate, and thickness of the nail plate
control
Healthy volunteers aged 18-45 without any diseases/drugs affecting the nail
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Isotretinoin
The effects of isotretinoin on morphology, growth rate, and thickness of the nail plate
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Using systemic or topical drugs with known effects on nail
* Having traumatic nail abnormalities (onychotillomania, nail biting, habit-tic deformity)
* Having no visible lunula
* Describing any trauma (including cutting or filing nails) between the two measurements
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sinan Özçelik
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sinan Özçelik
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sinan Özçelik, MD
Role: PRINCIPAL_INVESTIGATOR
Balıkesir Üniversitesi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Balikesir University
Balıkesir, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19AKD93
Identifier Type: -
Identifier Source: org_study_id